Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:RANI News 31 October 2025 - 28 November 2025

RANI Stock Today, 28 November 2025: Price Action, Options Expiry and Outlook After the $1 Billion Chugai Deal

RANI Stock Today, 28 November 2025: Price Action, Options Expiry and Outlook After the $1 Billion Chugai Deal

Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) is finishing November with quieter headlines but still very lively trading. As of today, 28 November 2025, the biotech micro‑cap is consolidating after its spectacular October surge on the back of a transformative collaboration with Japan’s Chugai Pharmaceutical and a $60.3 million private placement that extended its cash runway into 2028. Reuters+2Stock Titan+2 Crucially for anyone looking for “RANI stock news today”: Below is a detailed, Google News–friendly breakdown of where RANI stands today, what’s driving sentiment, and what to watch next. RANI stock price on 28 November 2025 Across major data providers, RANI
28 November 2025
·····
RANI Stock Today (Nov 19, 2025): Rani Therapeutics slips to $1.75 as traders weigh October’s Chugai deal and year‑end catalysts

RANI Stock Today (Nov 19, 2025): Rani Therapeutics slips to $1.75 as traders weigh October’s Chugai deal and year‑end catalysts

Updated: November 19, 2025 Rani Therapeutics Holdings (NASDAQ: RANI) finished Wednesday, Nov. 19, 2025 at $1.75, down from $1.86 on Tuesday. The stock opened at $1.83, traded between $1.70–$1.90, and moved ~2.5M shares on the day, according to end‑of‑day pricing data. Yahoo Finance Today’s trading at a glance (19.11.2025) Was there fresh company news today?As of publication on Nov. 19, no new Rani press releases or material company updates were posted today. The most recent company news remains the Q3 2025 results issued Nov. 6. Rani Therapeutics, LLCLikewise, no new SEC filings were posted today; the latest notable filing was
20 November 2025
····
Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Rani Therapeutics (RANI) Rockets 51% on Obesity Pill Breakthrough and $1B Pharma Deal

Stock Price and Recent Performance RANI has seen explosive moves this month. As of the Oct 31 close, Rani Therapeutics stock was $2.20 (up $0.75, +51.7%)stockanalysis.com. This follows a monumental rally: on Oct 17, RANI nearly tripled from ~$0.47 to an intraday high of $2.39 (+248%)ts2.techstockanalysis.com after the company announced the Chugai collaboration and financing. Even after that spike, RANI remained volatile – it spent mid-October around $1.50–2.50, briefly crossing Nasdaq’s $1 bid threshold and greatly lifting its market cap. Volume has been extremely high: for example, ~172 million shares traded on Oct 20 and ~124 million on Oct 21stockanalysis.com, versus an average of only
31 October 2025
····

Stock Market Today

Boeing stock climbs on India’s $70–80 billion aircraft pledge as Saudia talks keep demand in focus

Boeing stock climbs on India’s $70–80 billion aircraft pledge as Saudia talks keep demand in focus

7 February 2026
New York, February 6, 2026, 20:46 EST — Market closed. Boeing Co (NYSE: BA) shares closed up 2.6% at $243.03 on Friday, tracking a broader rally in U.S. industrials as investors weighed fresh signals of long-cycle aircraft demand. (Yahoo Finance) The move matters going into Monday because Boeing’s stock has been trading on two things at once: new order flow and the hard work of turning backlog into deliveries. Orders support the story, but deliveries drive cash, and that gap has punished the stock before. India’s Trade Minister Piyush Goyal said the United States and India expect to sign a
Nebius (NBIS) stock jumps 16% into weekend as AI trade whipsaws; earnings next week in focus

Nebius (NBIS) stock jumps 16% into weekend as AI trade whipsaws; earnings next week in focus

7 February 2026
Nebius shares jumped 16.6% to $86.10 on Friday, rebounding from a 10.3% drop Thursday. The company will report fourth-quarter and full-year 2025 results before the market opens on Feb. 12. U.S. jobs and inflation data are due next week after a delay from a government shutdown. Recent swings in Nebius stock followed volatility in AI-linked tech names after Alphabet’s spending update.
Go toTop